Proof of Usefulness Report

Mign

Analysis completed on 2/8/2026

+200
Proof of Usefulness Score
Gaining Momentum

Mign is a verified medical technology company (founded 2019) specializing in 3D-printed custom wearables (scoliosis bracing) with a proprietary design engine ('Genysis'). External search confirms seed funding (approx. $17M valuation implies verifiable investor backing) and media coverage (PBS). However, the project submission contained highly inaccurate and hyperbolic claims (e.g., 'most people have used my product', 'audience reach: everyone'), which severely degraded the data quality. The score reflects the project's genuine high utility and technical innovation, balanced against a niche actual market size and significant penalties for unreliable submission data.

Ready to Compete for $150k+ in Prizes?

Move this data into a HackerNoon blog draft to become eligible for your share of $150k+ in cash and software prizes

View All Reports

Score Breakdown

Real World Utility+92.0
Audience Reach Impact+8.0
Technical Innovation+61.2
Evidence Of Traction+24.5
Market Timing Relevance+34.0
Functional Completeness+2.0
Subtotal+221.7
Usefulness Multiplierx0.90
Final Score+200

Project Details

Project URL
Description
mign is a process of precision and sensitivity. Premiere 3D designers turn your complex data into a mign medical wearable that expertly addresses your physical needs and gives a boss nod to your character. You lead. We listen. It’s a mign thing. Our Genysis design engine deftly synthesizes your clinical requirements and body data for a beautifully personalized design.

Algorithm Insights

Market Position
Growing utility with room for optimization
User Engagement
Documented reach suggests active user community
Technical Stack
Modern tech stack aligned with sponsor technologies

Recommendations to Increase Usefulness Score

Document User Growth

Provide specific metrics on user acquisition and retention rates

Showcase Revenue Model

Detail sustainable monetization strategy and current revenue streams

Expand Evidence Base

Include testimonials, case studies, and third-party validation

Technical Roadmap

Share development milestones and feature completion timeline